COMPARATIVE CYTOTOXIC AND ANTI-TUMORAL EFFECTS OF ELLIPTICINE DERIVATIVES ON MOUSE-L-1210 LEUKEMIA

被引:95
作者
PAOLETTI, C [1 ]
CROS, S [1 ]
XUONG, ND [1 ]
LECOINTE, P [1 ]
MOISAND, A [1 ]
机构
[1] CNRS, CHIM SUBST NAT LAB, F-91190 GIF SUR YVETTE, FRANCE
关键词
D O I
10.1016/0009-2797(79)90068-1
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Twelve derivatives of the antitumoral alkaloid ellipticine (E) and elliptic inium were assayed in vitro on cultured L 1210 cells. These drugs possess varying abilities to decrease the cell growth rate in a 1-1000-fold range. Some of them have a highly cytotoxic effect in the 10-8-10-6 M range. Non-specific intracellular damages are produced: multilobation of the nuclei, occurrence of numerous lipid granules, diminution of the size and increase in the number of mitochondrial profiles and several modifications of the internal architecture of mitochondria. 2-Methyl-9-hydroxyellipticinium (2-CH3-9-OHE) was submitted to a bioassay; it inactivates the tumorigenic potency of the cellis exposed to it, when they are grafted back into mice in the same dose range which reduces in vitro the growth rate of the cells. A fairly good correlation holds between the in vitro and in vivo (antitumor effect) assays, offering a possible prescreening test for a cheaper and rapid evaluation of chemotherapeutic activity of these compounds. The results stress again the importance of the 9-hydroxy substitution in these series for improving the anticancer efficiency. The nature of the biochemical target of E and derivatives is discussed according to our data. © 1979.
引用
收藏
页码:45 / 58
页数:14
相关论文
共 27 条
  • [1] EFFECTS OF 9-HYDROXYELLIPTICINE ON GROWTH AND MACROMOLECULAR-SYNTHESIS IN ESCHERICHIA-COLI
    ALAZARD, R
    BOQUET, PL
    PAOLETTI, C
    [J]. FEBS LETTERS, 1976, 63 (02): : 278 - 282
  • [2] BARILE MF, 1973, CONTAMINATION TISSUE, P132
  • [3] SCREENING FOR ANTI-CANCER AGENTS - RELATIVE MERITS OF INVITRO AND INVIVO TECHNIQUES
    CONNORS, TA
    PHILLIPS, BJ
    [J]. BIOCHEMICAL PHARMACOLOGY, 1975, 24 (24) : 2217 - 2223
  • [4] TOXICOLOGICAL AND PHARMACOLOGICAL STUDIES ON 9-HYDROXY-ELLIPTICINE IN MICE
    CROS, S
    SORBARA, R
    MOISAND, C
    DATXUONG, N
    LECOINTE, P
    PAOLETTI, C
    [J]. TOXICOLOGY AND APPLIED PHARMACOLOGY, 1975, 33 (03) : 484 - 497
  • [5] SYNTHESIS OF TUMOUR-INHIBITORY ALKALOIDS ELLIPTICINE 9-METHOXYELLIPTICINE AND RELATED PYRIDO[4,3-B]CARBAZOLES
    DALTON, LK
    DEMERAC, S
    ELMES, BC
    LODER, JW
    SWAN, JM
    TEITEI, T
    [J]. AUSTRALIAN JOURNAL OF CHEMISTRY, 1967, 20 (12) : 2715 - &
  • [6] NEW DNA INTERCALATING DRUG - METHOXY-9-ELLIPTICINE
    FESTY, B
    POISSON, J
    PAOLETTI, C
    [J]. FEBS LETTERS, 1971, 17 (02): : 321 - +
  • [7] FONTAINE.D, 1969, CR ACAD SCI D NAT, V269, P406
  • [8] GOLDIN A, 1974, CANCER CHEMOTH REP 1, V58, P63
  • [9] Hartwell JL, 1969, ADV PHARMACOL CHEMOT, V7, P117, DOI 10.1016/S1054-3589(08)60561-X
  • [10] PRELIMINARY TRIAL OF 9-HYDROXY-2-METHYL ELLIPTICINIUM (NSC 264-137) IN ADVANCED HUMAN CANCERS
    JURET, P
    TANGUY, A
    GIRARD, A
    LETALAER, JY
    ABBATUCCI, JS
    DATXUONG, N
    LEPECQ, JB
    PAOLETTI, C
    [J]. EUROPEAN JOURNAL OF CANCER, 1978, 14 (02) : 205 - 206